This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Glaxosmithkline Biologicals Sa, Glaxosmithkline Intellectual Property Development Limited. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2021
Title: Jeanne-Marie Josephine Devaster: Innovator in Immunogenic Compositions
Introduction
Jeanne-Marie Josephine Devaster is a notable inventor based in Rixensart, Belgium. She has made significant contributions to the field of immunology, particularly in the development of treatments for chronic obstructive pulmonary disease (COPD). Her work focuses on creating immunogenic compositions that can help prevent acute exacerbations caused by bacterial infections.
Latest Patents
Jeanne-Marie holds a patent for an immunogenic composition, which includes an immunogenic polypeptide and its fragments. This invention is aimed at treating or preventing the recurrence of acute exacerbations of chronic obstructive pulmonary disease (AECOPD). The innovative approach she has developed is crucial for improving the quality of life for patients suffering from this condition.
Career Highlights
Throughout her career, Jeanne-Marie has worked with prominent organizations, including GlaxoSmithKline Intellectual Property Development Limited and GlaxoSmithKline Biologicals SA. Her experience in these companies has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Jeanne-Marie has collaborated with notable colleagues, including Catherine Cohet and David Mayhew. These partnerships have enriched her research and have been instrumental in advancing her innovative projects.
Conclusion
Jeanne-Marie Josephine Devaster is a pioneering inventor whose work in immunogenic compositions has the potential to transform the treatment of chronic obstructive pulmonary disease. Her contributions to the field highlight the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile